Clinical trial
Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors: A Multicenter Phase III Non-Inferiority Randomized Controlled Trial
NCT04400357 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors: A Multicenter Phase III Non-Inferiority Randomized Controlled Trial
- Lead sponsor
- Ruijin Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 28, 2020
- Completion date
- February 28, 2025
- Enrollment
- 268 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ampullary adenocarcinoma, cholangiocarcinoma, extrahepatic, chronic pancreatitis, duodenal adenocarcinoma, pancreatic adenocarcinoma, pancreatic cysts, pancreatic endocrine tumors